Paper29174792
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.
Schiffenbauer A and 11 others. Semin Arthritis Rheum, 2018. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis. Papers, record 29174792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29174792
- Disease
- dermatomyositis48 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dermatologic Agents | Major topic |
| Dermatomyositis | Major topic |
| Immunosuppressive Agents | Major topic |
| Infliximab | Major topic |
| Adult | |
| Cross-Over Studies | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilot Projects | |
| Prednisone | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z99 ES999999 | Intramural NIH HHS | United States | Z99ES999999 | PubMed | NIH RePORTER |
| ZIAES101081 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00033891 | Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis | Derived from the trial | Yes |
Source ClinicalTrials.gov
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8557829 | Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. | J Neuroimmunol | 1995 | https://conductscience.org/library/papers/8557829 | PubMed |
| 2 | 21132303 | Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity. | Rheumatol Int | 2012 | https://conductscience.org/library/papers/21132303 | PubMed |
| 3 | 1090839 | Polymyositis and dermatomyositis (first of two parts). | N Engl J Med | 1975 | https://conductscience.org/library/papers/1090839 | PubMed |
| 4 | 9153548 | Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. | Arthritis Rheum | 1997 | https://conductscience.org/library/papers/9153548 | PubMed |
| 5 | 11055823 | Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis. | Clin Rheumatol | 2000 | https://conductscience.org/library/papers/11055823 | PubMed |
| 6 | 12824706 | Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. | Eur Neurol | 2003 | https://conductscience.org/library/papers/12824706 | PubMed |
| 7 | 10399751 | Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. | Neuromuscul Disord | 1999 | https://conductscience.org/library/papers/10399751 | PubMed |
| 8 | 18403404 | Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. | Rheumatology (Oxford) | 2008 | https://conductscience.org/library/papers/18403404 | PubMed |
| 9 | 22955021 | Therapeutic advances in myositis. | Curr Opin Rheumatol | 2012 | https://conductscience.org/library/papers/22955021 | PubMed |
| 10 | 21926626 | Clinical trials roundup in idiopathic inflammatory myopathies. | Curr Opin Rheumatol | 2011 | https://conductscience.org/library/papers/21926626 | PubMed |
| 11 | 22324944 | Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. | Int J Rheum Dis | 2012 | https://conductscience.org/library/papers/22324944 | PubMed |
| 12 | 22110532 | The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/22110532 | PubMed |
| 13 | 23024713 | Novel approaches in the treatment of myositis and myopathies. | Ther Adv Musculoskelet Dis | 2012 | https://conductscience.org/library/papers/23024713 | PubMed |
| 14 | 22588740 | Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). | Arthritis Care Res (Hoboken) | 2011 | https://conductscience.org/library/papers/22588740 | PubMed |
| 15 | 21688301 | A randomized, pilot trial of etanercept in dermatomyositis. | Ann Neurol | 2011 | https://conductscience.org/library/papers/21688301 | PubMed |
| 16 | 12610824 | Defining Clinical Improvement in Adult and Juvenile Myositis. | J Rheumatol | 2003 | https://conductscience.org/library/papers/12610824 | PubMed |
| 17 | 10805105 | Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. | Acta Neuropathol | 2000 | https://conductscience.org/library/papers/10805105 | PubMed |
| 18 | 27320359 | Diagnosis and classification of idiopathic inflammatory myopathies. | J Intern Med | 2016 | https://conductscience.org/library/papers/27320359 | PubMed |
| 19 | 17165006 | Polymyositis associated with infliximab treatment for rheumatoid arthritis. | Mod Rheumatol | 2006 | https://conductscience.org/library/papers/17165006 | PubMed |
| 20 | 16966313 | Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM). | Phys Occup Ther Pediatr | 2006 | https://conductscience.org/library/papers/16966313 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42760264 | Flares and definition of worsening in inflammatory myopathies: a narrative review of the literature. | Rheumatology (Oxford) | 2026 | https://conductscience.org/library/papers/42760264 | PubMed |
| 42488644 | Convergent innate immune and regulated cell-death pathways in selected myopathies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488644 | PubMed |
| 41371271 | Targeted Therapy for Idiopathic Inflammatory Myopathy. | J Cachexia Sarcopenia Muscle | 2025 | https://conductscience.org/library/papers/41371271 | PubMed |
| 40787733 | Non-targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40787733 | PubMed |
| 40747756 | Targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40747756 | PubMed |
| 40181992 | The role of monocytes and macrophages in idiopathic inflammatory myopathies: insights into pathogenesis and potential targets. | Front Immunol | 2025 | https://conductscience.org/library/papers/40181992 | PubMed |
| 39609094 | Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial. | Arthritis Rheumatol | 2025 | https://conductscience.org/library/papers/39609094 | PubMed |
| 38700458 | Paradoxical and bimodal immune-mediated dermatological side effects of TNF-α inhibitors: A comprehensive review. | Skin Res Technol | 2024 | https://conductscience.org/library/papers/38700458 | PubMed |
| 38166943 | Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial. | Pediatr Rheumatol Online J | 2024 | https://conductscience.org/library/papers/38166943 | PubMed |
| 37842905 | A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons. | Expert Rev Clin Immunol | 2024 | https://conductscience.org/library/papers/37842905 | PubMed |
| 36538023 | Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies. | Biosci Rep | 2023 | https://conductscience.org/library/papers/36538023 | PubMed |
| 35457124 | Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35457124 | PubMed |
| 35394612 | Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options. | Neurotherapeutics | 2022 | https://conductscience.org/library/papers/35394612 | PubMed |
| 35091780 | Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis. | Clin Rheumatol | 2022 | https://conductscience.org/library/papers/35091780 | PubMed |
| 34857798 | Idiopathic inflammatory myopathies. | Nat Rev Dis Primers | 2021 | https://conductscience.org/library/papers/34857798 | PubMed |
| 34857780 | Idiopathic inflammatory myopathies. | Nat Rev Dis Primers | 2021 | https://conductscience.org/library/papers/34857780 | PubMed |
| 33842655 | Environmental triggers of dermatomyositis: a narrative review. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33842655 | PubMed |
| 33614683 | Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/33614683 | PubMed |
| 33530460 | Monoclonal Antibodies as Neurological Therapeutics. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33530460 | PubMed |
| 33362394 | Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report. | World J Gastroenterol | 2020 | https://conductscience.org/library/papers/33362394 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| INFLIXIMAB | CHEMBL1201581 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201581 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29174792
GET https://conductscience.org/api/papers/v1/29174792/references?page=2